Skip to main content

Table 6 Correlation analysis of antibody levels against synthetic bDIDO1, bCPSF2, and bFOXJ2 peptides with data of subjects in the Sawara Hospital cohort

From: Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke

Present disease

 

HD

DSWMH

asympt-CI

TIA

AIS

cCI

 Sample number

 

188

162

18

66

351

66

 DIDO1pep-Ab level

Average

3381

3523

3481

4443

4688

4347

 

SD

1660

1750

2099

2576

2740

3017

 P value (vs HD)

 

–

ns

ns

< 0.01

< 0.001

< 0.05

 FOXJ2-Ab level

Average

4627

4995

4902

5794

6298

7022

 

SD

1972

2232

1854

2368

3308

5646

 P value (vs HD)

 

–

ns

ns

< 0.01

< 0.001

< 0.001

 CPSF2-Ab level

Average

7322

7571

8312

11,778

8722

10,088

 

SD

3415

2942

2461

16,843

3970

4240

 P value (vs HD)

 

–

ns

< 0.05

< 0.01

< 0.001

< 0.001

Sex

 

Male

Female

    

 Sample number

 

528

389

    

 DIDO1pep-Ab level

Average

4081

4038

    
 

SD

2493

2244

    

 P value (vs Male)

  

0.781

    

 FOXJ2-Ab level

Average

5772

5443

    
 

SD

3077

3084

    

 P value (vs male)

  

0.111

    

 CPSF2-Ab level

Average

8633

8420

    
 

SD

5493

6553

    

 P value (vs male)

  

0.155

    

Complication

 

DM−

DM+

    

 Sample number

 

732

180

    

 DIDO1pep-Ab level

Average

4059

4047

    
 

SD

2469

2027

    

 P value (vs DM−)

  

0.949

    

 FOXJ2-Ab level

Average

5589

5763

    
 

SD

3104

2987

    

 P value (vs DM−)

  

0.488

    

 CPSF2-Ab level

Average

8319

9437

    
 

SD

5373

7822

    

 P value (vs DM−)

  

0.015

    

Complication

 

HT−

HT+

    

 Sample number

 

347

565

    

 DIDO1pep-Ab level

Average

3830

4196

    
 

SD

2217

2477

    

 P value (vs HT−)

  

0.021

    

 FOXJ2-Ab level

Average

5093

5948

    
 

SD

2373

3405

    

 P value (vs HT−)

  

< 0.0001

    

 CPSF2-Ab level

Average

7699

9065

    
 

SD

6095

5804

    

 P value (vs HT−)

  

< 0.0001

    

Complication

 

CVD−

CVD+

    

 Sample number

 

861

51

    

 DIDO1pep-Ab level

Average

4003

4966

    
 

SD

2360

2673

    

 P value (vs CVD−)

  

0.015

    

 FOXJ2-Ab level

Average

5559

6712

    
 

SD

3050

3408

    

 P value (vs CVD−)

  

0.022

    

 CPSF2-Ab level

Average

8499

9232

    
 

SD

6037

4239

    

 P value (vs CVD−)

  

0.142

    

Complication

 

Lipidemia−

Lipidemia+

    

 Sample number

 

649

263

    

 DIDO1pep-Ab level

Average

4158

3806

    
 

SD

2497

2073

    

 P value (vs Lipidemia−)

 

0.029

    

 FOXJ2-Ab level

Average

5702

5428

    
 

SD

3171

2841

    

 P value (vs Lipidemia−)

 

0.203

    

 CPSF2-Ab level

Average

8146

9531

    
 

SD

3583

9534

    

 P value (vs Lipidemia−)

 

0.145

    

Lifestyle

 

Non-smoker

Smoker

    

 Sample number

 

474

441

    

 DIDO1pep-Ab level

Average

3732

4425

    
 

SD

2037

2676

    

 P value (vs non-smoker)

 

< 0.0001

    

 FOXJ2-Ab level

Average

5192

6111

    
 

SD

2793

3309

    

 P value (vs non-smoker)

 

< 0.0001

    

 CPSF2-Ab level

Average

8214

8901

    
 

SD

6086

5801

    

 P value (vs non-smoker)

 

0.002

    

Lifestyle

 

Alcohol−

Alcohol+

    

 Sample number

 

334

581

    

 DIDO1pep-Ab level

Average

4001

4103

    
 

SD

2236

2476

    

 P value (vs Alcohol−)

  

0.527

    

 FOXJ2-Ab level

Average

5691

5603

    
 

SD

3542

2793

    

 P value (vs Alcohol−)

  

0.698

    

 CPSF2-Ab level

Average

8559

8591

    
 

SD

6946

5341

    

 P value (vs Alcohol−)

  

0.361

    
  1. The subjects were divided as follows: sex (male and female); presence (+) or absence (−) of complication of DM, hypertension (HT), cardiovascular disease (CVD), or dyslipidemia, and lifestyle factors (smoking and alcohol intake habits). Antibody levels (Alpha counts) were compared using the Kruskal–Wallis test (upper panel) and the Mann–Whitney U test (lower panels). Sample numbers, averages, and SDs of counts as well as P values are shown. Significant correlations (P < 0.05) are marked in bold